New LaunchApr 28, 2026, 08:06 AM
VIVS Launches AI Tool for Drug-Induced Diarrhea with 96% Accuracy
AI Summary
VivoSim Labs, Inc. announced the launch of an AI prediction tool that leverages its NAMkind ™ intestinal models to accurately predict drug-induced diarrhea with 96% accuracy. The VitroSense ™ tool integrates proprietary NAMkind ™ ileum and colon tissues with advanced machine-learning analytics, trained on dozens of compounds. This breakthrough aims to transform cancer treatments by reducing reliance on animal models and identifying toxic liabilities in novel compounds.
Key Highlights
- VivoSim launched an AI prediction tool with 96% accuracy for drug-induced diarrhea.
- The tool leverages NAMkind ™ intestinal models and VitroSense ™ machine learning.
- It integrates proprietary NAMkind ™ ileum and colon tissues with advanced analytics.
- The model was trained using dozens of compounds and real-world 3D NAM assay results.
- NAMkind ™ intestine models can mimic oral or IV administration routes.
- NAMkind ™ liver and small intestine toxicology services are available in US, Europe, Korea, and China.
Price Impact
More from VIVS